This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
R&D collaboration building on Lead Pharma’s expertise in the discovery, design and optimization of smallmolecule treatments.
Lead Pharma is headquartered at Pivot Park, the biopharmaceutical life sciences campus in Oss, the Netherlands.
OSS, Netherlands , Nov.
OSS, Netherlands , Nov.
Between 2000 and 2020, approximately 30 percent of the newly introduced smallmolecule drugs were derived from natural products. About the authors August Allen August has a decade of experience building high throughput automation, scaling teams, and solving problems at the intersection of technology and life sciences.
The applications of artificial intelligence for enzyme generation is an exciting field of research with direct applications in the life sciences. Advances in these scientific challenges are a critical necessity to further advance drug discovery, environmental science, and bioengineering.
The majority of smallmolecule drugs induce their therapeutic effects by seeking out and binding to their intended target while avoiding most other molecules in the dense milieu of the cell interior. Our overall mission at Arrakis is to expand the set of “druggable” targets for small-molecule medicines to include RNA.
Once a new drug target is identified, a proprietary deep learning artificial intelligence (AI) platform we call Fluency can rapidly identify smallmolecules that selectively bind to a target of interest. Our assays and bioinformatics modelling can help identify certain indications that are appropriate for DCI while ruling others out.
A preprint from Microsoft AI Research provided a broad catalog of potential LLM applications in the physical and life sciences. Ren and coworkers from the Chinese Academy of Sciences published a preprint with one approach to overcoming some limitations of scoring structure-based generative models.
With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Rising from Research Scientist to Senior Scientist, I supported early-stage DD efforts within their Protein Science group, based in Cambridge, UK.
Cresset delivers software solutions and contract research expertise enabling companies around the world to accelerate their smallmolecule discovery processes efficiently and effectively. Customers include the pharmaceutical, biotechnology and agrochemical industries.
NantWorks and ImmunityBio Chief Executive Officer, Patrick Soon-Shiong , believes that science has reached the point where it is ready to pit a “triangle offense” against even the toughest cancers. A Whole New ‘Science Matters’ Perspective . “I And then, always, ‘science matters.’ Read on for more. .
Drugs that were developed and commercialised 30+ years ago were relatively simple smallmolecules. Todays smallmolecules are far larger, more complex, and chase highly specific (and difficult to hit) targets, thereby increasing the chances of undesired side effects. This failure is getting more pronounced by the day.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content